| Mr Jonathan Jude Reed, MD | |
|
10 Hospital Dr, Saint Peters, MO 63376-1659 | |
| (314) 525-1900 | |
| (314) 525-4868 |
| Full Name | Mr Jonathan Jude Reed |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Location | 10 Hospital Dr, Saint Peters, Missouri |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1437223146 | NPI | - | NPPES |
| 215050155 | Other | CPIN @ ST ANTHONYS | |
| 1437223146 | Medicaid | MO | |
| 206271801 | Medicaid | MO |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 2002008841 (Missouri) | Primary |
| Entity Name | Bc Missouri Emergency Physicians, Llp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1538184106 PECOS PAC ID: 9032023502 Enrollment ID: O20040112000147 |
News Archive
Brown & Toland Physicians is helping combat heart disease this year as a supporter of the American Heart Association Bay Area.
Researchers at the Medical University of Vienna, Austria, have made an important discovery about the immune response to coronaviruses in pangolins that could point to new approaches for treating human cases of infection.
Scientists have used plants to create a new polio vaccine in what is hoped to be a breakthrough in the way vaccines are made.
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering breakthrough treatments for human disease, announced top-line results from a recently completed Phase 2a study of LX2931 in patients with rheumatoid arthritis (RA). LX2931 is an orally-delivered, small molecule drug candidate that inhibits sphingosine-1-phosphate (S1P) lyase, an enzyme important for modulating the immune system by controlling S1P levels in lymphoid tissues.
Prolonged television watchers have a higher risk of fatal pulmonary embolism, a condition associated with long haul flights, reveals research presented at ESC Congress today by Mr Toru Shirakawa, public health research fellow in the Department of Social Medicine at Osaka University in Japan.
› Verified 5 days ago
| Entity Name | Lake Forest Emergency Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023261716 PECOS PAC ID: 1759441884 Enrollment ID: O20081119000794 |
News Archive
Brown & Toland Physicians is helping combat heart disease this year as a supporter of the American Heart Association Bay Area.
Researchers at the Medical University of Vienna, Austria, have made an important discovery about the immune response to coronaviruses in pangolins that could point to new approaches for treating human cases of infection.
Scientists have used plants to create a new polio vaccine in what is hoped to be a breakthrough in the way vaccines are made.
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering breakthrough treatments for human disease, announced top-line results from a recently completed Phase 2a study of LX2931 in patients with rheumatoid arthritis (RA). LX2931 is an orally-delivered, small molecule drug candidate that inhibits sphingosine-1-phosphate (S1P) lyase, an enzyme important for modulating the immune system by controlling S1P levels in lymphoid tissues.
Prolonged television watchers have a higher risk of fatal pulmonary embolism, a condition associated with long haul flights, reveals research presented at ESC Congress today by Mr Toru Shirakawa, public health research fellow in the Department of Social Medicine at Osaka University in Japan.
› Verified 5 days ago
| Entity Name | Bridgeton Emergency Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1053660076 PECOS PAC ID: 5193978948 Enrollment ID: O20130104000140 |
News Archive
Brown & Toland Physicians is helping combat heart disease this year as a supporter of the American Heart Association Bay Area.
Researchers at the Medical University of Vienna, Austria, have made an important discovery about the immune response to coronaviruses in pangolins that could point to new approaches for treating human cases of infection.
Scientists have used plants to create a new polio vaccine in what is hoped to be a breakthrough in the way vaccines are made.
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering breakthrough treatments for human disease, announced top-line results from a recently completed Phase 2a study of LX2931 in patients with rheumatoid arthritis (RA). LX2931 is an orally-delivered, small molecule drug candidate that inhibits sphingosine-1-phosphate (S1P) lyase, an enzyme important for modulating the immune system by controlling S1P levels in lymphoid tissues.
Prolonged television watchers have a higher risk of fatal pulmonary embolism, a condition associated with long haul flights, reveals research presented at ESC Congress today by Mr Toru Shirakawa, public health research fellow in the Department of Social Medicine at Osaka University in Japan.
› Verified 5 days ago
| Entity Name | Fenton Emergency Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1770832792 PECOS PAC ID: 4789837923 Enrollment ID: O20130121000081 |
News Archive
Brown & Toland Physicians is helping combat heart disease this year as a supporter of the American Heart Association Bay Area.
Researchers at the Medical University of Vienna, Austria, have made an important discovery about the immune response to coronaviruses in pangolins that could point to new approaches for treating human cases of infection.
Scientists have used plants to create a new polio vaccine in what is hoped to be a breakthrough in the way vaccines are made.
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering breakthrough treatments for human disease, announced top-line results from a recently completed Phase 2a study of LX2931 in patients with rheumatoid arthritis (RA). LX2931 is an orally-delivered, small molecule drug candidate that inhibits sphingosine-1-phosphate (S1P) lyase, an enzyme important for modulating the immune system by controlling S1P levels in lymphoid tissues.
Prolonged television watchers have a higher risk of fatal pulmonary embolism, a condition associated with long haul flights, reveals research presented at ESC Congress today by Mr Toru Shirakawa, public health research fellow in the Department of Social Medicine at Osaka University in Japan.
› Verified 5 days ago
| Entity Name | Newton Emergency Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1386292969 PECOS PAC ID: 8921413386 Enrollment ID: O20210216003189 |
News Archive
Brown & Toland Physicians is helping combat heart disease this year as a supporter of the American Heart Association Bay Area.
Researchers at the Medical University of Vienna, Austria, have made an important discovery about the immune response to coronaviruses in pangolins that could point to new approaches for treating human cases of infection.
Scientists have used plants to create a new polio vaccine in what is hoped to be a breakthrough in the way vaccines are made.
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering breakthrough treatments for human disease, announced top-line results from a recently completed Phase 2a study of LX2931 in patients with rheumatoid arthritis (RA). LX2931 is an orally-delivered, small molecule drug candidate that inhibits sphingosine-1-phosphate (S1P) lyase, an enzyme important for modulating the immune system by controlling S1P levels in lymphoid tissues.
Prolonged television watchers have a higher risk of fatal pulmonary embolism, a condition associated with long haul flights, reveals research presented at ESC Congress today by Mr Toru Shirakawa, public health research fellow in the Department of Social Medicine at Osaka University in Japan.
› Verified 5 days ago
| Entity Name | Missouri Care Services Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1518540277 PECOS PAC ID: 2365847696 Enrollment ID: O20210824002575 |
News Archive
Brown & Toland Physicians is helping combat heart disease this year as a supporter of the American Heart Association Bay Area.
Researchers at the Medical University of Vienna, Austria, have made an important discovery about the immune response to coronaviruses in pangolins that could point to new approaches for treating human cases of infection.
Scientists have used plants to create a new polio vaccine in what is hoped to be a breakthrough in the way vaccines are made.
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering breakthrough treatments for human disease, announced top-line results from a recently completed Phase 2a study of LX2931 in patients with rheumatoid arthritis (RA). LX2931 is an orally-delivered, small molecule drug candidate that inhibits sphingosine-1-phosphate (S1P) lyase, an enzyme important for modulating the immune system by controlling S1P levels in lymphoid tissues.
Prolonged television watchers have a higher risk of fatal pulmonary embolism, a condition associated with long haul flights, reveals research presented at ESC Congress today by Mr Toru Shirakawa, public health research fellow in the Department of Social Medicine at Osaka University in Japan.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mr Jonathan Jude Reed, MD 75 Remit Drive, Lockbox 1940, Chicago, IL 60675-1940 Ph: (866) 916-5255 | Mr Jonathan Jude Reed, MD 10 Hospital Dr, Saint Peters, MO 63376-1659 Ph: (314) 525-1900 |
News Archive
Brown & Toland Physicians is helping combat heart disease this year as a supporter of the American Heart Association Bay Area.
Researchers at the Medical University of Vienna, Austria, have made an important discovery about the immune response to coronaviruses in pangolins that could point to new approaches for treating human cases of infection.
Scientists have used plants to create a new polio vaccine in what is hoped to be a breakthrough in the way vaccines are made.
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering breakthrough treatments for human disease, announced top-line results from a recently completed Phase 2a study of LX2931 in patients with rheumatoid arthritis (RA). LX2931 is an orally-delivered, small molecule drug candidate that inhibits sphingosine-1-phosphate (S1P) lyase, an enzyme important for modulating the immune system by controlling S1P levels in lymphoid tissues.
Prolonged television watchers have a higher risk of fatal pulmonary embolism, a condition associated with long haul flights, reveals research presented at ESC Congress today by Mr Toru Shirakawa, public health research fellow in the Department of Social Medicine at Osaka University in Japan.
› Verified 5 days ago
Joy Stowell, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 6994 Mexico Rd, Saint Peters, MO 63376 Phone: 636-397-3231 | |
Heather Webb, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 10 Hospital Dr, Saint Peters, MO 63376 Phone: 636-916-9000 | |
George Mekhjian, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 10 Hospital Dr, Saint Peters, MO 63376 Phone: 636-916-9000 Fax: 314-317-0606 | |
Jeffrey Schwartz, M.D., FACEP Emergency Medicine Medicare: Medicare Enrolled Practice Location: 10 Hospital Dr, Saint Peters, MO 63376 Phone: 636-916-9000 | |
Scott Landry, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 10 Hospital Dr, Saint Peters, MO 63376 Phone: 636-916-9000 | |
Jose Marino Parra, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 201 Bjc Saint Peters Dr, Ste. 200, Saint Peters, MO 63376 Phone: 636-916-9615 Fax: 636-916-9850 |